Sign in
CompletedNo phase

Ablation in Brugada Syndrome for the Prevention of VF

Key facts

Who runs it
Pacific Rim Electrophysiology Research Institute
Where
Netherlands and Thailand6 sites in 2 countriesChoose a country to see its sites
Trial code
Status
Completed
People taking part
200 people enrolled
Started
Jul 2016
Ended
13 Nov 2024
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Catheter Ablation
Record updated
21 November 2024

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • The diagnosis of Brugada syndrome is based on 2013 HRS/EHRA/APHRS Consensus document criteria
  • Diagnosed symptomatic BrS with an implanted ICD within the last 5 years
  • Diagnosed symptomatic BrS with an implanted ICD longer than 5 years but has at least 1 appropriate shock within the last 5 years
  • The patient is legally competent, willing and able to undergo the study and signed the informed consent
  • The patient is willing and able to adhere to the follow-up visit protocol

Who cannot take part

  • A patient who has had a previous epicardial ablation
  • A patient with a co-morbid condition that possesses undue risk of general anesthesia or epicardial ablation
  • A patient who has a history of radiation therapy on the thorax
  • A patient who does not meet inclusion criteria
  • A patient who is pregnant (which would exclude an ablation procedure)

This trial has no sites in United States.

It has sites in 2 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

This trial aims to develop evidence based curative treatment with optimal net benefit for patients with Brugada syndrome.

The 3 groups in the trial

  • Control armNo study treatment, for comparison

    Control arm - continued implanted cardioverter defibrillator therapy

  • Intervention ArmExisting treatment, for comparison

    ablation of areas of fragmented signal in the right ventricular outflow tract plus continued implanted cardioverter defibrillator therapy

    Treatment: Catheter Ablation

  • Single Cross Over ArmOther group

    these patients were initially assigned to the control arm of the study. When these patients met the primary outcome of the study it is allowed for these patients to be included in the intervention arm and/or to start quinidine

    Treatment: Catheter Ablation

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Ablation in Brugada Syndrome for Prevention of VF - A Randomized, Multi-center Study of Epicardial Ablation in Brugada Syndrome Patients to Prevent Arrhythmia Recurrence
Record updated
21 November 2024